IRON$78.582.80%-2.26
Nachbörslich: 78.62+0.04 +0.05%
Disc Medicine Inc (IRON)
Date: 2026-11-02 16:00O: 80.99H: 81.69L: 78.04C: 78.58Vol: 340.6k
Schlusskurs vom Vortag:
$80.84
Offen:
$80.99
24-Stunden-Volumen:
340,592
Relatives Volumen:
0.21
Marktkapitalisierung:
$3.49B
Einnahmen:
-
Nettoeinkommen (Verlust:
-$241.60M
KGV:
-
EPS:
-$6.62
Netto-Cashflow:
-$201.34M
1W Leistung:
+1.18%
1M Leistung:
+21.81%
6M Leistung:
+17.44%
1Y Leistung:
-8.86%
1-Tages-Spanne:
$78.04$81.69
1-Wochen-Bereich:
$76.50$85.00
52-Wochen-Spanne:
$40.00$99.50
Disc Medicine Inc Aktie (IRON) Unternehmensprofil
Firmenname
Disc Medicine IncSektor
HealthcareBranche
BiotechnologyTelefon
(617) 674-9274Adresse
321 ARSENAL STREET, SUITE 101, WATERTOWN, USAIRON vs. VRTX, REGN, MRNA, ARGX, ONC vergleichen
| Aktien | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|
IRON Disc Medicine Inc | $3.49B | $0 | -$245.89M | -$197.58M | -$6.62 |
 VRTX Vertex Pharmaceuticals Inc | $140.94B | $12.59B | $4.41B | $3.80B | $16.87 |
 REGN Regeneron Pharmaceuticals Inc | $99.46B | $16.90B | $4.82B | $3.83B | $41.04 |
 MRNA Moderna Inc | $88.17B | $2.23B | -$3.15B | -$1.24B | -$8.15 |
 ARGX Argen X Se Adr | $55.03B | $4.16B | $1.29B | $734.26M | $19.58 |
 ONC Beone Medicines Ltd Adr | $40.86B | $6.13B | $655.71M | $1.33B | $4.48 |
Disc Medicine Inc Aktie (IRON) Hochstufungen & Herabstufungen
Finanzdaten der Disc Medicine Inc-Aktie (IRON)
Disc Medicine Inc-Aktie (IRON) Insiderhandel
- Bitterman KevinOct 21 '26Director
- Transaktion
- Sale
- Kosten
- $80.23
- #Aktien
- 25,519
- Wert ($)
- 2,047,389
- #Aktien Gesamt
- 12,991
- Atlas Venture Opportunity FundOct 21 '26Shareholder
- Transaktion
- Proposed Sale
- Kosten
- $79.48
- #Aktien
- 11,470
- Wert ($)
- 911,636
- #Aktien Gesamt
- 0
- Atlas Venture Opportunity FundOct 21 '26Shareholder
- Transaktion
- Proposed Sale
- Kosten
- $79.48
- #Aktien
- 13,783
- Wert ($)
- 1,095,473
- #Aktien Gesamt
- 0
- Atlas Venture Fund X, LPOct 21 '26Shareholder
- Transaktion
- Proposed Sale
- Kosten
- $79.48
- #Aktien
- 33,461
- Wert ($)
- 2,659,480
- #Aktien Gesamt
- 0
- Atlas Venture Fund XII, LPOct 21 '26Shareholder
- Transaktion
- Proposed Sale
- Kosten
- $79.48
- #Aktien
- 266
- Wert ($)
- 21,142
- #Aktien Gesamt
- 0
- Bitterman KevinOct 20 '26Director
- Transaktion
- Sale
- Kosten
- $79.95
- #Aktien
- 5,312
- Wert ($)
- 424,694
- #Aktien Gesamt
- 13,257
- Atlas Venture Opportunity FundOct 20 '26Shareholder
- Transaktion
- Proposed Sale
- Kosten
- $78.93
- #Aktien
- 2,388
- Wert ($)
- 188,485
- #Aktien Gesamt
- 0
- Atlas Venture Fund X, LPOct 20 '26Shareholder
- Transaktion
- Proposed Sale
- Kosten
- $78.93
- #Aktien
- 6,965
- Wert ($)
- 549,747
- #Aktien Gesamt
- 0
- Atlas Venture Opportunity FundOct 20 '26Shareholder
- Transaktion
- Proposed Sale
- Kosten
- $78.93
- #Aktien
- 2,869
- Wert ($)
- 226,450
- #Aktien Gesamt
- 0
- Atlas Venture Fund XII, LPOct 20 '26Shareholder
- Transaktion
- Proposed Sale
- Kosten
- $78.93
- #Aktien
- 55
- Wert ($)
- 4,341
- #Aktien Gesamt
- 0
